MAPK3 and osteosarcoma: Herein, we display a powerful ERK1/2 phosphorylation in both AdipoR-treated osteosarcoma cells that seems to mediate cell cycle slowdown on one side (U2OS), and both cell cycle brake and cell death on the other side (Saos-2).